Literature DB >> 12018878

Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy.

Alan Cheng1, Joel B Braunstein, Cheryl Dennison, Caitlin Nass, Roger S Blumenthal.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death and disability in industrialized societies, due in large part to the lack of a comprehensive approach to control the risk factors for atherosclerosis. One strategy for reducing an individual's global CVD risk relies on a targeted approach that modifies each of the major independent risk factors prevalent in both symptomatic (secondary prevention) and asymptomatic (primary prevention) patients. These interventions include lipid lowering, smoking cessation, blood pressure control, glycemic control, regular exercise, and the use of various medications. This review offers an evidence-based strategy toward reducing an individual's global risk for CVD by addressing the modifiable, major independent risk factors.

Entities:  

Mesh:

Year:  2002        PMID: 12018878      PMCID: PMC6653857          DOI: 10.1002/clc.4950250503

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  7 in total

1.  Cardiovascular health among adults in Syria: a model from developing countries.

Authors:  Wasim Maziak; Samer Rastam; Fawaz Mzayek; Kenneth D Ward; Thomas Eissenberg; Ulrich Keil
Journal:  Ann Epidemiol       Date:  2007-06-06       Impact factor: 3.797

2.  Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?

Authors:  Ramit Ravona-Springer; Michael Davidson; Shlomo Noy
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

3.  Prevalence and correlates of coronary heart disease: first population-based study in Lebanon.

Authors:  Rouba Karen Zeidan; Rita Farah; Mirna N Chahine; Roland Asmar; Hassan Hosseini; Pascale Salameh; Atul Pathak
Journal:  Vasc Health Risk Manag       Date:  2016-03-17

4.  Prevalence, risk awareness and health beliefs of behavioural risk factors for cardiovascular disease among university students in nine ASEAN countries.

Authors:  Karl Peltzer; Supa Pengpid
Journal:  BMC Public Health       Date:  2018-02-13       Impact factor: 3.295

5.  Metabolic Syndrome and Cognitive Functions in Schizophrenia-Implementation of Dietary Intervention.

Authors:  Katarzyna Adamowicz; Aleksandra Mazur; Monika Mak; Jerzy Samochowiec; Jolanta Kucharska-Mazur
Journal:  Front Psychiatry       Date:  2020-04-30       Impact factor: 4.157

6.  The socioeconomic burden of coronary heart disease in Korea.

Authors:  Hoo-Sun Chang; Han-Joong Kim; Chung-Mo Nam; Seung-Ji Lim; Young-Hwa Jang; Sera Kim; Hye-Young Kang
Journal:  J Prev Med Public Health       Date:  2012-09-28

7.  Are cardiovascular risk factors associated with verbal learning and memory impairment in patients with schizophrenia? A cross-sectional study.

Authors:  Christophe Lancon; Daniel Dassa; Jessica Fernandez; Raphaelle Richieri; Romain Padovani; Laurent Boyer
Journal:  Cardiovasc Psychiatry Neurol       Date:  2012-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.